GlassScriptPhysician profile
Lora Wallis Kahn
NPI 1326332388
$24,461.68
in general payments reported to CMS, 2019-2025
16 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,303 · 2020: $231 · 2021: $454 · 2022: $4,056 · 2023: $362 · 2024: $12K · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,450 · Travel and Lodging: $2,715 · Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,450.00 |
| Travel and Lodging | $2,714.82 |
| Food and Beverage | $1,252.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,667.40 | 2021-2025 | Visualase, Percept PC Brainsense, Activa PC |
| Medtronic USA, INC. | $6,982.95 | 2019-2020 | |
| Brainlab, INC. | $3,609.12 | 2022 | |
| Insightec,INC | $1,127.98 | 2019-2024 | Exablate |
| Boston Scientific Corporation | $770.80 | 2020-2024 | |
| Spine Wave, INC. | $298.79 | 2020-2021 | |
| Abbott Laboratories | $242.25 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $174.95 | 2019-2022 | |
| Sk Life Science, INC. | $157.93 | 2024 | |
| Integra Lifesciences Corporation | $151.27 | 2023 | Codman Certas, Cusa Clarity, Codman Hakim |
| Livanova USA, INC. | $58.35 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Globus Medical, INC. | $51.42 | 2024 | Excelsiusgps Robotic Navigation System |
| Bioventus LLC | $31.99 | 2023 | Bonescalpel |
| Aesculap, INC. | $30.88 | 2019 | |
| Neuropace, INC. | $25.18 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $17.86 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.